You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Samarium sm-153 lexidronam pentasodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for samarium sm-153 lexidronam pentasodium and what is the scope of freedom to operate?

Samarium sm-153 lexidronam pentasodium is the generic ingredient in one branded drug marketed by Lantheus Medical and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for samarium sm-153 lexidronam pentasodium
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 6
DailyMed Link:samarium sm-153 lexidronam pentasodium at DailyMed
Recent Clinical Trials for samarium sm-153 lexidronam pentasodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NRG OncologyPhase 3
National Cancer Institute (NCI)Phase 3
Radiation Therapy Oncology GroupPhase 3

See all samarium sm-153 lexidronam pentasodium clinical trials

US Patents and Regulatory Information for samarium sm-153 lexidronam pentasodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medical QUADRAMET samarium sm-153 lexidronam pentasodium INJECTABLE;INJECTION 020570-001 Mar 28, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.